ProKidney Corp. Marketable Securities, Unrealized Gain (Loss)
ProKidney Corp. (PROK) reported Marketable Securities, Unrealized Gain (Loss) of $19.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-10
- ProKidney Corp. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was $19.00K.
- ProKidney Corp. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$109.00K.
- ProKidney Corp. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was -$18.00K.
- ProKidney Corp. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $44.00K, a 86.54% decline year-over-year.
- ProKidney Corp. marketable securities, unrealized gain (loss) for fiscal 2025 was -$74.00K.
- ProKidney Corp. marketable securities, unrealized gain (loss) for fiscal 2023 was $130.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-10 | -$90.00K 10-Q · filed 2026-08-10 | -$108.00K derived: sum of 3 quarters · filed 2026-08-10 | -$64.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$109.00K 10-Q · filed 2026-05-15 | -$127.00K derived: sum of 2 quarters · filed 2026-05-15 | -$83.00K derived: sum of 3 quarters · filed 2026-05-15 | -$128.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $26.00K derived: sum of 2 quarters · filed 2026-03-18 | -$19.00K derived: sum of 3 quarters · filed 2026-08-10 | -$74.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $44.00K 10-Q · filed 2025-11-10 | -$1.00K derived: sum of 2 quarters · filed 2026-08-10 | -$56.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$45.00K 10-Q · filed 2026-08-10 | -$100.00K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | -$55.00K 10-Q · filed 2026-05-15 | |||
| 2024-09-30 | $327.00K 10-Q · filed 2025-11-10 | $365.00K derived: sum of 2 quarters · filed 2025-11-10 | $191.00K 10-Q · filed 2025-11-10 | $385.00K derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-06-30 | $38.00K 10-Q · filed 2025-08-12 | -$136.00K 10-Q · filed 2025-08-12 | $58.00K derived: sum of 3 quarters · filed 2026-03-18 | $121.00K derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-03-31 | -$174.00K 10-Q · filed 2025-05-12 | $20.00K derived: sum of 2 quarters · filed 2026-03-18 | $83.00K derived: sum of 3 quarters · filed 2026-03-18 | -$25.00K derived: sum of 4 quarters · filed 2026-03-18 |
| 2023-12-31 | $194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $257.00K derived: sum of 2 quarters · filed 2026-03-18 | $149.00K derived: sum of 3 quarters · filed 2026-03-18 | $130.00K 10-K · filed 2026-03-18 |
| 2023-09-30 | $63.00K 10-Q · filed 2024-11-12 | -$45.00K derived: sum of 2 quarters · filed 2024-11-12 | -$64.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$108.00K 10-Q · filed 2024-08-09 | -$127.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$19.00K 10-Q · filed 2024-05-10 |